Phase 1 Pneumonia Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
Pneumonia, Bacterial
GlaxoSmithKline120 enrolled2 locationsNCT07428759
Recruiting
Phase 1
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
Streptococcus Pneumoniae
Pfizer372 enrolled5 locationsNCT07086677
Recruiting
Phase 1
An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults
VaccineKlebsiella Pneumoniae Infection
Cho Pharma Inc.40 enrolled1 locationNCT07016152
Recruiting
Phase 1Phase 2
The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia
Pneumonia Childhood
Mian Muhammad Hassan Ahmed60 enrolled1 locationNCT06949904
Recruiting
Phase 1
Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol
Pneumonia
Institut National de la Santé Et de la Recherche Médicale, France60 enrolled1 locationNCT06681402
Recruiting
Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses
Severe Viral Pneumonia(Not Include COVID-19)
Ruijin Hospital60 enrolled1 locationNCT06693362
Recruiting
Phase 1
Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia
COVID-19 pneumonia
Royal Perth Hospital Cell & Tissue Therapies WA10 enrolled2 locationsACTRN12620000840987